Contaminated surfaces are an established route of transmission for many nosocomial pathogens, including both bacteria and viruses [Otter, 2016]. Viruses with pandemic potential including SARS-CoV, MERS-CoV, and influenza virus can survive on surfaces for extended periods of time, sometimes up to months, [Otter, 2016].
SARS-CoV-2 (the virus that causes COVID-19) has been found to be stable on plastic and stainless steel for up to 72 hours, [van Doremalen, 2020]. In a recent study, surface samples were collected from the rooms of COVID-19 patients, and environmental surface contamination was found in the rooms of 66.7% of patients, [Chia, 2020].
Infection prevention and control measures should include enhanced surface cleaning and disinfection in healthcare settings [Otter, 2016]. This is of particular significance when managing COVID-19 patients where viral RNA has been extensively detected on surfaces underlining the need for effective surface hygiene [Zhou, 2020].
When selecting disinfectants for use in clinical settings, compromise is not an option. This is why the mikrozid® offers an extensive range of products for the rapid cleaning and disinfection of surfaces.
Available as ready to use wipes or liquid, all mikrozid® products:
mikrozid® liquid and wipes contain a unique blend of two alcohols for a very high performance against viruses and bacteria., mikrozid is ideal for the rapid disinfection of non-invasive medical devices and surfaces in clinical areas with an increased risk of infection and where short contact times are required.
mikrozid® universal liquid and wipes offer a unique low alcohol formulation with a blend of two alcohols. mikrozid universal is ideal for use when a material friendly disinfectant is needed, including the surfaces of keyboards and touch pads of sensitive equipment, smartphones and tablets.
mikrozid® alcohol free wipes and liquid are especially suitable for surfaces sensitive to alcohol such as leather, PVC and acrylic glass.
mikrozid® – the science of safe surfaces
For more information, please contact Schülke & Mayr UK Ltd on 0114 254 35 00, mail.uk@schuelke.com or visit www.schuelke.com.
References
Chia PY, Coleman KK, Tan YK, et al. Detection of air and surface contamination by SARS-CoV-2 in hospital rooms of infected patients. Nat Commun. 2020;11(1):2800. Published 2020 May 29. doi:10.1038/s41467-020-16670-2
van Doremalen N, Bushmaker T, Morris DH, et al. Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1. N Engl J Med. 2020;382(16):1564-1567. doi:10.1056/NEJMc2004973
Otter JA, Donskey C, Yezli S, Douthwaite S, Goldenberg SD, Weber DJ. Transmission of SARS and MERS coronaviruses and influenza virus in healthcare settings: the possible role of dry surface contamination. J Hosp Infect. 2016;92(3):235-250. doi:10.1016/j.jhin.2015.08.027
Zhou J, Otter JA, Price JR, et al. Investigating SARS-CoV-2 surface and air contamination in an acute healthcare setting during the peak of the COVID-19 pandemic in London [published online ahead of print, 2020 Jul 8]. Clin Infect Dis. 2020;ciaa905. doi:10.1093/cid/ciaa905
